source
- Syntax Bio claims four-day stem-cell conversion into pancreatic beta cellsChicago-based Syntax Bio says its Cellgorithm platform can turn stem cells into pancreatic beta cells in as little as four days. The company describes the process as a programmable set of epigeneti…
- Artiva Biotherapeutics cuts 94% of workforce after patient deaths and failed autoimmune cell therapyArtiva Biotherapeutics announced it is halting development of its AlloNK natural killer cell therapy for autoimmune diseases and is laying off roughly 94% of its employees. The AlloNK product, an…